Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Escitalopram in Depressive Patients with Acute Coronary Artery Syndrome
NCT00419471Phase 4Completed
- Sponsor
- Chonnam National University Hospital
- Start
- May 2007
- Primary completion
- Mar 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of escitalopram in major depressive disorder (MDD), sponsored by Chonnam National University Hospital. Primary endpoint: Hamilton Depression Rating Scale-17 item at 24 weeks. Started May 2007; status: completed.
02
Drugs
escitalopram
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on NCT00419471.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00419471.